Loading clinical trials...
Loading clinical trials...
An Open Label Extension Study to Assess the Safety of Long-Term Treatment With a 4 mL Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee
Conditions
Interventions
4 mL injection of AMPION™
Locations
11
United States
Central Research Associates, Inc.
Birmingham, Alabama, United States
CORE Orthopaedic Medical Center
Encinitas, California, United States
St. Joseph Heritage
Fullerton, California, United States
Westlake Medical Research
Thousand Oaks, California, United States
Drug Studies America
Marietta, Georgia, United States
Healthcare Research Netword
Blue Island, Illinois, United States
Start Date
December 8, 2017
Primary Completion Date
October 4, 2018
Completion Date
October 4, 2018
Last Updated
October 3, 2022
Lead Sponsor
Ampio Pharmaceuticals. Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions